CLOV vs NTLA
Clover Health Investments Corp (CLOV) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
CLOV currently screens at market cap $1.55B. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the CLOV and NTLA stock pages for the full models.
Not investment advice.